Addendum Announcement from Dr.Soliman Abdel Kader Fakeeh Hospital Company with regards to the company’s announcement on 03/12/2025 about the signing of a share purchase agreement to acquire a 50.01% equity stake in Diagnostic Elite.
| Element List | Explanation |
|---|---|
| Introduction | Dr. Soliman Abdulkader Fakeeh Hospital Company (“DSFH”) and its subsidiaries (“Fakeeh Care Group”, “Group”, “Fakeeh Care”) announced on 03/12/2025 that it entered into a binding share purchase agreement to acquire a 50.01% equity stake in Diagnostic Elite Company (“Diagnostic Elite”) from Soliman Abdul-Qader Fakeeh Real Estate Company (“Fakeeh Real Estate”), without profit to the seller. We would like to clarify that the agreement was signed on 02/12/2025G (11/06/1447H) with the following parties to the transaction:
1. Dr. Soliman Abdulkader Fakeeh Hospital Company (“DSFH”) – buyer. 2. Soliman Abdul-Qader Fakeeh Real Estate Company (“Fakeeh Real Estate”) – seller. 3. Diagnostic Elite Company – target.
Existing shareholders of Diagnostic Elite: • Soliman Abdul-Qader Fakeeh Real Estate Company (“Fakeeh Real Estate”): Holds 30,506 shares out of 61,000 issued shares, representing 50.01% of the company’s share capital. • The founders (six consultant radiologists): Collectively hold 30,494 shares out of 61,000 issued shares, representing approximately 49.99% of the company’s share capital, namely: Dr. Ahmed Haitham Abduljabbar; Dr. Amr Mohammadhassan Ajlan; Dr. Ayman Abdulmoqtader Eskandar; Dr. Mohammad Abdulrahim Wazzan; Dr. Khalid Ghalib Khashoggi; Dr. Turki Ahmed Alhazmi. |
| Date of Posting the Previous Announcement of Development on Saudi Exchange’s Website | 2025-12-03 Corresponding to 1447-06-12 |
| Hyperlink to the Previous Announcement | Click Here |
| Change on the Development | NA |
| Financial Impact on the change | NA |
| Additional Information | NA |
Comments